OpenDue February 20, 2029·Synced from source June 27, 2026
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Who can apply
Small businessPrivate universitiesSchool districtsPublic universitiesTribal governmentsNonprofits
About this opportunity
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) - Federal funding opportunity from National Institutes of Health. Full description and eligibility details will be available after enrichment completes. Visit the Grants.gov detail page for complete information.
Finding similar opportunities...